Sign In
test

Jonathan Isler, Deerfield UGP, LLC, its general partner

Deerfield Management Company, L.p.

Assets Managed
$8.476B
Holdings
82
Last Quarter
2026 - Q1
Filed Date
23d ago
Growth Rate
8.26%(2Q avg: 13.9%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Deerfield Management Company, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 82 positions.

Assets under management

The assets under management (AUM) of Deerfield Management Company, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 8.476B in assets, with a quarterly growth rate of 8.26% and a 2-quarter average growth rate of 13.9%. The portfolio is managed by Jonathan Isler, Deerfield UGP, LLC, its general partner, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
NUVL
Nuvalent Inc-a
Recent Activity
20.85%
$1.767B
17.248M shares@ $102.46 avg price
ur-1⤦
Brookdale Sr Living Inc
Recent Activity
5.97%
$505.441M
306.885M shares@ $1.65 avg price
COGT
Cogent Biosciences Inc
Recent Activity
4.11%
$348.1M
9.044M shares@ $38.49 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 6.65%
3.67%
$310.382M
963,351 shares@ $322.2 avg price
VTRS
Viatris Inc
Recent Activity
3.23%
$272.985M
20.206M shares@ $13.52 avg price
UTHR
United Therapeutics Corp
Recent Activity
Increased 7.28%
3.2%
$270.992M
457,000 shares@ $592.98 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Decreased -20.64%
2.64%
$223.383M
2.297M shares@ $97.25 avg price
ur-8⤦
Mirum Pharmaceuticals Inc
Recent Activity
2.48%
$209.44M
70M shares@ $3.0 avg price
ur-1⤦
Arrowhead Pharmaceuticals In
Recent Activity
New Position
2.45%
$207.182M
200M shares@ $1.04 avg price
CELC
Celcuity Inc
Recent Activity
2.31%
$195.636M
1.714M shares@ $114.14 avg price

1-10 of 82